Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic
  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Acorda Therapeutics halts study enrollment

Acorda Therapeutics Inc. (Nasdaq: ACOR) halted new enrollments in its Phase 3 study of tozadenant to treat Parkinson's disease after five deaths. Shares of the biopharmaceutical plummeted $11.20 to close at $17.00.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.